Pharmacology of Pain Flashcards

1
Q

Give the definitions of pain vs nociception

how do they relate

A

Pain: An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage

Nociception: The neural process of encoding noxious stimuli.

activation of a nociceptor can be considered sufficient, but not necessary, for the experience of pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 types of nociceptor fibre

A

Nociceptors are either thinly myelinated Aδ-fibres or unmyelinated C-fibres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the stoma and axon terminals of nociceptors

A

cell bodies are located in the dorsal root ganglia (DRG; trigeminal ganglia, TG, for the head) and their axon terminals do not have specialised endings, rather so-called free-endings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 steps for the transmission of pain information along a nociceptor

A

(1). If receptor potential depolarisation is great enough, NaVs are activated (2); action potential propagation to the presynaptic terminals in the spinal cord results in the opening of voltage-gated calcium channels (CaVs) and Ca2+ influx results in the release of neurotransmitters on to postsynaptic terminals in the spinal cord (3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
For each of the following noxious stimuli, state which ion channels are activated:
Temperature
Protons
ATP
mechanical stimuli
A
  • Heat = TRPV1, TRPM3, anoctamin-1, and TRPA1, and cold = TRPM8, TRPA1 (yes, senses both)
  • Protons = ASICs, TRPV1, TASKS
  • ATP = P2X3
  • Mechanical stimuli = Piezo1/2, TRPV4?, ASICs?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you measure nociceptor activation

A

Nociceptor cell bodies can be isolated from DRG/TG, cultured and patch-clamp electrophysiology recordings made

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or false

sensitization does not occur in nociceptors

A

false
Sensitisation is a property characteristic of nociceptors: when a stimulus is great enough to cause tissue damage, the response to subsequent stimuli increases. Stimuli that usually cause pain now result in more pain (hyperalgesia) and previously innocuous stimuli now cause pain (allodynia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give an everyday example of allodynia

A

taking a shower when sunburned – hot water that would usually cause no pain now does!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are allodynia and hyperalgesia reflected electrically in nociceptors

A

decreased response threshold (allodynia) and greater response (hyperalgesia) when compared to response before sensitisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 types of external stimuli that are capable of exciting a nociceptor

A

thermal, mechanical, or chemical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give 3 examples of internal stimuli that excite nociceptors

A

ATP (released from damaged cells), bradykinin (formed by kallikrein cleaving kininogen) and acid (released by anaerobic metabolism during anoxia or metabolic overload).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are sensitising agents

A

do not directly excite the nociceptive nerve terminals, but instead enhance responses to excitatory agents. This class includes prostaglandins and nerve growth factor (NGF).

Some agents both excite and sensitize nociceptors, examples include bradykinin, ATP and H+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do nociceptor nerve terminals release when stimulated

what does this lead to

A

eg as calcitonin gene-related peptide (CGRP) and substance P (SP), peptides that cause vasodilatation and an increase in the permeability of blood vessels; these effects are both direct and indirect through SP inducing mast-cell degranulation.

The inflammation caused by the release of CGRP and SP from nerve terminals causes a redness (“flare”) surrounding the site of injury and is referred to as neurogenic inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What 2 reactions does COX catalyse

A

AA is first cyclised and oxygenated forming the endoperoxide PGG2; the hydroperoxyl in PGG2 is then reduced to form PGH2. PGE synthase produces PGE2 from PGH2, which acts to sensitise nociceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does PGE2 bring about nociceptor sensitisation

give the cascade and how it is modified

A

There are 4 EP receptors and EP4 appears particularly important in inflammatory pain because its expression is upregulated. EP4 is Gs-coupled resulting in increased adenylate cyclase activity, cAMP production and thus activation of PKA and other signalling pathways.

One pathway for sensitisation involves PKA phosphorylation of the NaV isoform NaV1.8, which reduces its activation threshold meaning that a smaller depolarisation is able to evoke action potential firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is neuropathic pain

A

Peripheral nerve damage can result in pain that often outlasts the initial nerve injury, sometimes indefinitely
Following initiation in the periphery, changes in nociceptive processing at spinal and higher centres are likely involved in disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

give 5 examples of neuropathic pain

A

progression

  • Phantom limb pain – sensation of pain in an amputated limb, long after its removal
  • Infectious diseases (e.g. HIV, leprosy and hepatitis)
  • Diabetic neuropathy
  • Trigeminal neuralgia
  • Post-herpetic neuralgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do NSAIDs work usually

A

by entering a hydrophobic channel on COX and forming hydrogen bonds with an Arg120, which prevents the entrance of fatty acids, like arachidonic acid, into the catalytic domain and preventing PG production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does aspirin differ from other NSAIDs

A

; it enters the active site and acetylates a serine at position 530, which irreversibly inactivates COX, an action that explains certain long-lasting actions of aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can some drugs be COX2 selective

A

The bulky side group of COX-2 enables some drugs with large, sulphur-containing side groups to selectively act upon COX-2, but not COX-1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Where are the different COX enzymes expressed

A

COX-1 is constitutive and expressed in many tissues, whereas COX-2 is induced in inflammatory cells when they are activated by, for example, cytokines such as TNF-α during inflammation (some tissues do have constitutive COX-2 activity )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why does NSAIDs’ inhibition of COX enzymes result in pain reduction

A

results in decreased PGE2 synthesis and thus less nociceptor sensitisation and less pain; nociceptor excitability is returned to the resting, normal state. Because certain PGs are powerful vasodilators (PGE2 and PGI2), pain relief in headache may also result from decreased vasodilation of the cerebral vasculature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

For which conditions are NSAIDs most effective

A

inflammatory conditions when COX-2 is upregulated, e.g. arthritis, muscular pain, toothache, bursitis and dysmenorrhoea (period pain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the cardiovascular protective action of aspirin

A

inhibition platelet derived thromboxane – acetylated COX can be replaced by newly synthesised protein in cells, but thromboxane production by platelets is switched off for their lifetime (approx. 10 days).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Give information on ibuprofen

what is the non human equivalent

A

weakly COX-1 selective, symptomatic relief in rheumatoid arthritis, gout and soft tissue disorders

phenylbutazone (non-humans)

26
Q

Name a COX2 selective NSAID in humans and a nonhuman equivalent

A

Etoricoxib (humans)

robenacoxib (non-humans)

27
Q

What is etoricoxib used to treat

A

osteoarthritis and rheumatoid arthritis, only advised in patients for whom conventional NSAIDs pose a significant gastrointestinal risk and after an assessment of cardiovascular risk.

28
Q

Give the side effects of NSAIDs and give a reason for each side effect (4)

A

GI bleeding (PGs inhibit gastric acid secretion and increase the release of protective mucin, patients often take a drug to counteract the effects on acid secretion),

renal insufficiency (PGE2/PGI2 involved in maintenance of renal blood flow),

stroke/myocardial infarction (COX-2 is constitutively expressed in endothelial/vascular smooth muscle cells, inhibition results in decreased PGI2 production, PGI2 is vasodilatory and decreases platelet aggregation)

bronchospasm (COX inhibition implicated, mechanism unclear).

29
Q

What is an opioid vs an opiate

A

a substance producing morphine-like effects that are reversed by antagonists such as naloxone, an opiate is a substance found in the opium poppy Papaver somniferum.

30
Q

Which receptors do opiates act on

A

µ, κ, δ or ORL1.

31
Q

Which parts of opioid structure are important for function

A

free hydroxyl on the benzene ring and the nitrogen atom linked by 2 carbon atoms to the benzene ring are important for opioid activity

bulky substitution of the N atom introduces antagonist activity eg in naloxone.

32
Q

What type of receptor are all the opioid receptors

what is the result of their activation

A

GPCRs - Gi/Go-protein coupled

βγ subunit interacts with inwardly rectifying potassium channels, GIRKs, to promote opening (neuronal hyperpolarisation = action potential firing less likely) and to inhibit the opening of CaVs (mainly N-type; decreased Ca2+ entry = decreased neurotransmitter release). Adenylate cyclase activity is also decreased.

33
Q

What are the 3 levels opioids can act at

A

analgesia occurs due to action at peripheral, spinal and supraspinal levels.

34
Q

Describe the peripheral action of opioids

A

inhibition of adenylate cyclase activity counteracts the sensitising effect of PGs

35
Q

Describe the spinal analgesic action of opioids

A

dorsal horn opioids act presynaptically on nociceptors to decrease neurotransmitter release, as well as postsynaptically to reduce dorsal horn neurone excitability

36
Q

How do opioids act supraspinally

A

opioid injection into the brain has demonstrated roles for a number of brain areas, including the periaqueductal grey region, and that it may evoke the activation of endogenous inhibitory systems. Effects are largely µ-mediated. Opioids can also reduce the affective component of pain due to their ability to evoke euphoria, which is also µ-mediated.

37
Q

Through which receptor do opioids evoke euphoria

A

µ

38
Q

What are opioids used to treat (3)

A

both acute (e.g. post-operative) and chronic (e.g. cancer) pain,

not always considered sensible in treating neuropathic pain because the dose often needed to provide analgesia is coupled with excessive side effects.

39
Q

Give 5 examples of opioids

A
morphine
Diamorphine (heroin) 
codeine
Buprenoprhine 
Etorphine
40
Q

Why is heroine considered a prodrug

how does its action compare to that of morphine

A

analgesic activity is due to metabolism to 6-monoacetylmorphine and morphine

acts more rapidly than morphine when injected IV because of higher lipid solubility enabling better BBB penetration, subsequent deacetylation leads to analgesic

41
Q

How does codeine compare to morphine

how is codeine usually given

A

more reliably absorbed orally than morphine, but less analgesic (plus fewer side effects),

a prodrug, often given in combination with an NSAID for mild pain

42
Q

What is buprenorphine

what is a benefit of it

what is it used for

A

partial agonist that dissociates slowly and the combined high affinity / low efficacy means that it can antagonise other opioids.

Being a partial agonist, moderate analgesia alongside less respiratory depression than full agonists.

Often used for post-surgery pain in rodents, cats and dogs, used as a patch for treating chronic pain in humans

43
Q

Describe etorphine

A

1000 times more potent than morphine, used in veterinary medicine for large animal use

44
Q

What is naloxone

A

broad spectrum opioid receptor antagonist, rapidly reverses opioid effects, therefore used to reverse opioid-induced respiratory depression after overdose and in newborn baby following use of opioid analgesia during labour

45
Q

What is co-codamol

what is this an example of

A

paracetamol + codeine.

Many analgesics are combinations of an NSAID and an opioid: drugs inducing analgesia via different mechanisms should provide additive analgesia, therefore, less of each can be given thus lessening the side effects

46
Q

What are some side effects of opioids (4)

give a reason for each

A

respiratory depression (µ-mediated, combination of inhibition of respiratory rhythm and of central chemoreceptors),

nausea/vomiting (δ/µ-mediated)

constipation (µ, κ and δ-mediated).

Chronic use is complicated by tolerance and physical dependence.

47
Q

Can antidepressants be used to treat pain

what does this highlight the importance of

A

SSRIs, e.g. fluoxetine are largely inefficacious, but serotonin-noradrenaline reuptake inhibitors (SNRIs, e.g. duloxetine) and tricyclic antidepressants (TCAs, e.g. amitriptyline) also block serotonin and noradrenaline reuptake) provide relief in several forms of neuropathic pain;

presumably signifies an important role for descending inhibitory modulation of pain system from locus coeruleus involving noradrenaline.

48
Q

What is gabapentin

A

developed as a GABA analogue for treatment of epilepsy, has no activity at GABA receptors and is efficacious against neuropathic pain in some patients, no effect on acute pain

49
Q

What is the MOA of gabapentin

A

Appears to decrease the cell surface localisation of the CaV α2δ1 subunit.

The α2δ1 subunit usually causes an increase in CaV current density and is upregulated in some forms of neuropathic pain.

By decreasing α2δ1 subunit cell surface localisation, gabapentin decreases CaV current density and thus would decrease spinal cord neurotransmitter release

50
Q

What was the successor to gabapentin

A

Pregabalin - has better pharmacokinetics

51
Q

Name 2 Nav inhibitors which can be used for pain releif

A

lidocaine

carbamazepine

52
Q

What is lidocaine

A

a local anaesthetic that acts by blocking NaVs, can provide analgesia when applied topically as a patch – thought to provide analgesia by preventing spontaneous peripheral neurone discharges associated with neuropathic pain

53
Q

What is carbamazepine and what is it used to treat

A

blocks NaVV

used as an anti-epileptic, but also for treating neuropathic pain, especially trigeminal neuralgia

54
Q

What is ziconotide

A

Synthetic analogue of the N-type CaV blocker ω-conotoxin MVIIA

55
Q

Why is ziconotide only used where other treatments have failed

A

To prevent widespread, deleterious side effects it must be administered intrathecally; expensive, invasive (potentially dangerous route of administration)

56
Q

What is the pain ladder

A

published by WHO
3 steps: Step 1 = non-opioid (e.g. NSAID) ± adjuvant, Step 2 = weak opioid (e.g. codeine) ± non-opioid, ± adjuvant, and Step 3 = strong opioid (e.g. morphine) ± non-opioid, ± adjuvant;

57
Q

What are adjuvants in the pain ladder

A

additional painkillers, such as gabapentin

58
Q

What was the pain ladder developed for

A

developed specifically for cancer pain, works well for post-operative pain, less well for neuropathic pain.

59
Q

Name 2 targets for future analgesics

A

subunit specific NaV blockers (NaV1.7 – 9 have key roles in nociceptors/pain) and anti-NGF antibodies (e.g. tanezumab, is currently in a number of Phase 3 clinical trials)

60
Q

How well do NK1 receptor antagonists and TRPV1 antagonists work as analgesics

A

NK1 receptor antagonists efficacious in animal models, non-efficacious in humans

TRPV1 antagonists may be usefully therapeutically, but common problem of causing hyperthermia.